Offer - Urjas Oil for just ₹ 1 X
Pramipex 0.125 Tablet, a prescription drug, is manufactured in various forms such as Tablet. It is primarily used for the treatment of Parkinson's Disease. The alternative uses of Pramipex 0.125 Tablet have also been explained below.
The optimal dosage of Pramipex 0.125 Tablet is largely dependent on the individual's body weight, medical history, gender and age. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Refer to the dosage section for a detailed discussion.
Besides the aforementioned side effects, there are other adverse effects of Pramipex 0.125 Tablet as well, which are listed below. Usually, these side effects of Pramipex 0.125 Tablet go away soon, and do not persist beyond the duration of the treatment. However, if these continue for a longer time, consult your doctor right away.
In addition, Pramipex 0.125 Tablet's effect is Moderate during pregnancy and Severe for lactating mothers. Warnings related to Pramipex 0.125 Tablet's effects on the liver, heart and kidney, if any, have been listed below.
Individuals suffering from medical conditions like Schizophrenia, Heart Disease, Kidney Disease must refrain from the use of Pramipex 0.125 Tablet since this can cause severe adverse effects.
Besides this, Pramipex 0.125 Tablet may also have severe interaction with some medicines. See below for a complete list.
In addition to these precautions, you may also note that Pramipex 0.125 Tablet is not safe while driving, and is is not addictive in nature.
Pramipex 0.125 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Pramipex 0.125 Tablet safe for pregnant women?
Pramipex can cause unwanted side effects in pregnant women. If you experience any side effects, stop taking Pramipex right away. Take your doctor's advice before taking it again.
Is the use of Pramipex 0.125 Tablet safe during breastfeeding?
Women who are breastfeeding may experience severe harmful effects after taking Pramipex. It should only be taken after medical advice.
What is the effect of Pramipex 0.125 Tablet on the Kidneys?
Pramipex rarely harms the kidneys.
What is the effect of Pramipex 0.125 Tablet on the Liver?
There are no any side effects of Pramipex on the liver.
What is the effect of Pramipex 0.125 Tablet on the Heart?
Pramipex has very mild side effects on the heart.
If you are suffering from any of the following diseases, you should not take Pramipex 0.125 Tablet unless your doctor advises you to do so -
Is this Pramipex 0.125 Tablet habit forming or addictive?
Forming a habit of Pramipex 0.125 Tablet has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
After taking Pramipex 0.125 Tablet you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Pramipex 0.125 Tablet should be used only after doctor's advice.
Is it able to treat mental disorders?
Yes, this Pramipex 0.125 Tablet works for mental disorders.
Interaction between Food and Pramipex 0.125 Tablet
Taking Pramipex 0.125 Tablet with some specific foods may delay its effect. Talk to your doctor about this.
Interaction between Alcohol and Pramipex 0.125 Tablet
Consult your doctor before consuming alcohol while taking Pramipex 0.125 Tablet as it can have severe side effects.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Mirapex® (pramipexole dihydrochloride)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1043-1044
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 430-431